SNOA SNOA

Q: What is the current share price of SNOA?

As of 2026-08-05 17:25 PDT, SNOA trades at $1.13 on NASDAQ/NYSE. Its 52-week range is $1.01 to $5.35.

Q: What is the market capitalisation of SNOA?

SNOA has a market capitalisation of $2.03M on NASDAQ/NYSE.

Q: What is the P/E ratio of SNOA?

SNOA trades at a trailing price-to-earnings (P/E) ratio of -0.60. Its price-to-book (P/B) ratio is 0.66.

Q: What is the return on equity (ROE) of SNOA?

SNOA has a return on equity (ROE) of -102.58%. Its return on capital employed (ROCE) is -26.96%.

Q: Is SNOA a good stock to buy?

This page provides a data-driven analysis of SNOA, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Company Profile ↓

$1.13

-62.21% 1Y

Mkt Cap$2.03M

P/E-0.60

P/B0.66

52W High$5.35

52W Low$1.01

Book Value$1.72

EPS (TTM)$-1.89

Company Overview

SNOA (SNOA) is a publicly traded company listed on with a market capitalization of $2.03M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.27.

Recent Developments

Mar 2026 Revenue of $19.53M (+36.7% YoY); net profit $-3.17M.
Trailing 12 Months Year-on-year growth — revenue +36.7%.
5-Year Trend Long-term compounding — revenue CAGR 5.1%.

Growth & Price Performance

Compounded Sales Growth

5 Years:	5.08%
1 Year:	36.68%

Stock Price Performance

1 Year:	-62.21%
6 Months:	-65.02%
3 Months:	-8.13%
1 Month:	-8.13%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish

52-Week Range 3% of range

$1.01 $5.35

Trend Signals

Price vs 50-DMABelow
Price vs 200-DMABelow
RSI (14)44.95 · Neutral

Price Performance

1M-8.13%

3M-8.13%

6M-65.02%

1Y-62.21%

Auto-generated from price history and fundamentals; not investment advice.

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Period: Metric:

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

Trading 78.9% below its 52-week high.
In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Valuation

Stock P/E

-0.60

Industry PE

Forward P/E

PEG Ratio

Book Value

$1.72

Price to Book

0.66

P/S

EV/EBITDA

Dividend Yield

0.00%

Growth (CAGR)

Revenue 5Y

5.08%

Profit 5Y

Revenue (YoY)

36.68%

Earnings (YoY)

Profitability & Returns

ROCE

-26.96%

ROE

-102.58%

ROA

-22.74%

Profit Margin

-16.26%

Op Margin

-12.60%

Gross Margin

37.97%

EPS (Latest Qtr)

$-0.48

EPS (TTM)

$-1.89

Balance Sheet & Liquidity

Debt/Equity

0.27

Quick Ratio

1.75

Current Ratio

2.50

Debt

$842.00K

Total Assets

$13.96M

Current Assets

$12.10M

Working Capital

$7.27M

Ownership

Promoter Holding

0.42%

Chg in Prom Hold

FII / Inst Holding

1.42%

Chg in FII Hold

Financial Snapshot

Enterprise Value

Total Revenue (TTM)

$19.53M

EBITDA

$-2.32M

Free Cash Flow

$-4.12M

Operating Cash Flow

$-3.93M

Shares Outstanding

1.80M

Gross Margin

37.97%

Payout Ratio

Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric	Sep 2013	Dec 2013	Jun 2014	Sep 2014	Dec 2014	Jun 2015	Sep 2015	Dec 2015	Jun 2016	Sep 2016	Dec 2016	Jun 2017	Sep 2017	Dec 2017	Jun 2018	Sep 2018	Dec 2018	Jun 2019	Sep 2019	Dec 2019	Jun 2020	Sep 2020	Dec 2020	Jun 2021	Sep 2021	Dec 2021	Jun 2022	Sep 2022	Dec 2022	Jun 2023	Sep 2023	Dec 2023	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4.38M	4.73M	4.39M	5.77M	5.77M	4.94M	3.68M	3.74M	2.90M	3.98M	3.33M	2.94M	3.43M	2.73M	3.14M	3.39M	3.58M	-	3.75M	4.01M	5.60M	4.35M	5.56M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2.23M	2.55M	3.48M	2.70M	3.38M
Gross Profit	2.71M	2.11M	1.91M	1.73M	1.66M	1.87M	2.09M	455.00K	981.00K	1.04M	1.71M	1.76M	1.85M	2.37M	1.73M	2.43M	2.85M	2.18M	2.17M	2.00M	2.25M	2.50M	2.00M	1.45M	1.24M	1.20M	1.65M	1.54M	831.00K	1.20M	990.00K	1.46M	1.31M	1.36M	-	1.53M	1.46M	2.12M	1.65M	2.18M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2.18M	2.56M	2.46M	2.33M	2.53M
Operating Income	-1.27M	-1.55M	-1.51M	-1.54M	-1.95M	-2.31M	-1.86M	-4.19M	-3.51M	-2.99M	-3.56M	-3.38M	-2.86M	-3.20M	-3.55M	-2.65M	-2.35M	-1.91M	-1.29M	-1.11M	-665.00K	169.00K	-138.00K	-904.00K	-964.00K	-958.00K	-855.00K	-731.00K	-1.83M	-1.24M	-1.21M	-844.00K	-1.17M	-850.00K	-	-656.00K	-1.09M	-337.00K	-678.00K	-351.00K
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-625.00K	-1.06M	-301.00K	-644.00K	-318.00K
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-528.00K	-1.24M	-731.00K	-949.00K	-497.00K
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	248.00K	-1.00K	-197.00K	-130.00K	84.00K
Net Income	-1.40M	-611.00K	-70.00K	-718.00K	-5.91M	-2.34M	-1.76M	-3.15M	-2.57M	-1.95M	16.23M	-3.51M	-2.87M	-3.19M	-3.46M	-2.82M	-2.30M	715.00K	-1.20M	-1.08M	240.00K	120.00K	-650.00K	-1.10M	-100.00K	-944.00K	-887.00K	-1.02M	-1.94M	-1.42M	-1.48M	-866.00K	-1.14M	-610.00K	-	-776.00K	-1.24M	-534.00K	-819.00K	-581.00K
Diluted EPS	-	-	-	-	-	-	-	-0.96	-	-	3.84	-	-	-0.73	-4.99	-	-	0.54	-0.92	-	0.13	0.06	-0.32	-0.52	-0.04	-0.31	-0.29	-0.33	-0.62	-0.29	-5.75	-1.59	-1.34	-0.59	-0.63	-	-0.76	-0.32	-0.48	-
R&D Expense	883.00K	775.00K	439.00K	353.00K	367.00K	467.00K	412.00K	486.00K	360.00K	379.00K	487.00K	382.00K	368.00K	349.00K	350.00K	390.00K	451.00K	338.00K	270.00K	248.00K	476.00K	-85.00K	33.00K	84.00K	10.00K	26.00K	206.00K	200.00K	0	325.00K	536.00K	601.00K	470.00K	506.00K	427.00K	-	594.00K	575.00K	557.00K	-

Profit & Loss (Annual)

Figures in USD.

Metric	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Revenue	9.75M	12.74M	15.45M	13.67M	13.85M	9.37M	12.82M	16.66M	18.97M	17.93M	18.63M	-	13.27M	12.73M	14.29M	19.53M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	8.79M	7.99M	8.82M	12.11M
Gross Profit	6.14M	8.71M	10.74M	8.40M	7.29M	2.65M	5.67M	7.31M	8.88M	8.12M	6.56M	-	4.48M	4.75M	5.46M	7.42M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	9.05M	9.45M	9.18M	9.88M
Operating Income	-7.50M	-6.47M	-3.37M	-6.05M	-6.66M	-14.71M	-12.97M	-14.19M	-11.26M	-7.39M	-3.45M	-	-4.57M	-4.70M	-3.71M	-2.46M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-4.45M	-4.53M	-3.57M	-2.32M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-5.18M	-5.03M	-2.91M	-3.42M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-33.00K	-196.00K	550.00K	-244.00K
Net Income	-7.95M	-7.33M	-5.43M	3.73M	-8.20M	-10.16M	9.27M	-14.33M	-11.80M	-3.31M	-3.95M	-	-5.15M	-4.83M	-3.46M	-3.17M
Diluted EPS	-	-	-1.30	0.54	-0.85	-	-	-	-	-	-	-	-30.40	-10.63	-2.79	-1.89
R&D Expense	2.05M	1.98M	2.22M	2.89M	1.53M	1.81M	1.58M	1.57M	1.52M	1.34M	555.00K	125.00K	207.00K	1.87M	1.81M	2.27M

Balance Sheet (Annual)

Figures in USD.

Metric	Mar 2010	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Total Assets	-	8.66M	7.84M	12.56M	20.79M	15.05M	13.80M	25.46M	19.21M	14.45M	14.56M	14.99M	-	16.23M	14.74M	13.69M	13.96M
Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	13.80M	12.55M	12.65M	12.10M
Cash & Equivalents	6.26M	4.37M	3.35M	7.90M	5.48M	6.14M	7.47M	17.46M	10.07M	3.69M	3.69M	4.22M	-	3.82M	3.13M	5.37M	2.40M
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	2.86M	2.72M	2.92M	3.65M
Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	2.57M	2.90M	2.23M	2.53M
Total Liabilities	-	6.96M	8.71M	8.48M	8.73M	2.99M	3.66M	4.03M	3.88M	3.96M	8.94M	9.62M	-	8.25M	8.60M	9.28M	10.87M
Current Liabilities	-	4.42M	4.75M	5.13M	7.57M	2.58M	3.55M	3.29M	3.26M	3.59M	4.73M	4.08M	-	3.72M	3.72M	4.10M	4.83M
Long Term Debt	-	1.64M	1.82M	676.00K	4.00K	0	0	45.00K	32.00K	12.00K	0	1.31M	-	-	-	-	-
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	849.00K	608.00K	305.00K	842.00K
Total Equity	7.04M	1.70M	-868.00K	4.08M	12.06M	12.05M	10.14M	21.43M	15.33M	7.77M	5.62M	5.36M	-	7.98M	6.14M	4.41M	3.10M
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	246.68K	780.37K	1.63M	1.80M

Cash Flows (Annual)

Figures in USD.

Metric	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow	-4.43M	-4.03M	1.15M	-	-	-	-	-	-11.72M	-4.59M	-3.38M	-	-6.15M	-2.40M	-88.00K	-3.93M
Investing Cash Flow	-164.00K	-360.00K	-370.00K	-	-	-	-	-	-131.00K	3.64M	388.00K	-	-258.00K	-2.00K	-80.00K	-192.00K
Financing Cash Flow	2.68M	3.45M	3.75M	-	-	-	-	-	5.49M	1.03M	3.31M	-	2.49M	1.68M	3.03M	477.00K
Capital Expenditure	-174.00K	-336.00K	-257.00K	-504.00K	-139.00K	-345.00K	-394.00K	-187.00K	-100.00K	-206.00K	-179.00K	-	-269.00K	-2.00K	-80.00K	-192.00K
Free Cash Flow	-4.60M	-4.37M	893.00K	-	-	-	-	-	-11.82M	-4.80M	-3.56M	-	-6.42M	-2.40M	-168.00K	-4.12M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-	-	-	-3.92M	-724.00K	2.86M	-3.65M

Ratios (Annual)

Figures in %.

Metric	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Gross Margin %	63.0%	68.4%	69.5%	61.4%	52.6%	28.3%	44.2%	43.9%	46.8%	45.3%	35.2%	-	33.7%	37.3%	38.2%	38.0%
Operating Margin %	-76.9%	-50.7%	-21.8%	-44.3%	-48.1%	-157.0%	-101.2%	-85.2%	-59.3%	-41.2%	-18.5%	-	-34.4%	-36.9%	-26.0%	-12.6%
Net Margin %	-81.5%	-57.5%	-35.1%	27.3%	-59.2%	-108.5%	72.3%	-86.0%	-62.2%	-18.5%	-21.2%	-	-38.8%	-38.0%	-24.2%	-16.3%
ROE %	-467.3%	844.4%	-133.1%	31.0%	-68.1%	-100.2%	43.3%	-93.5%	-151.8%	-58.8%	-73.7%	-	-64.6%	-78.8%	-78.4%	-102.6%
ROCE %	-176.6%	-209.4%	-45.4%	-45.8%	-53.4%	-143.5%	-58.5%	-89.0%	-103.7%	-75.2%	-31.6%	-	-36.5%	-42.7%	-38.7%	-27.0%

Shareholding Pattern

Insiders

0.42%

Institutions

1.42%

Public Float

1.43%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for SNOA

Google News Fri, 24 Apr 2026

Sonoma Pharma prices nearly 3M shares to fund working capital - Stock Titan

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPcEtscG8tazZ3SlFqOUtvSXFLZkFEblZCMUZ2cXdKd1c1WUdqS1hvbFpmV1lEenpOMFRIZjRxbVp6cjU3SXVxR3I0WVpKM3NudXRBeEZYUU9BMWZ3SGF3WXFXRXc0b1FScWRRUkZnbFNMQVRyOXFpcEJBSVBzQkJXYlB1TXlLdTN0dEZQSk…

Google News hu, 30 Jul 2026

SNOA|Sonoma Pharmaceuticals Inc|Price:1.100|Chg%:-0.040 - TradingKey

<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE5YUzBaTnZMZ2hiMHhZYWl4VnRReUFuR1FHX0ZldUpaZ0NCQUY2TDFRblhSRTR4T3Z3cEg2Q1MwTm5JVVlkQUVRMFRPMEpjY1poQUJYcW1BMzdmamstN05SR3NFa3NEMmxTRm93UXRR?oc=5" target="_blank">SNOA|Sonoma Pharmac…

Google News Wed, 14 Jan 2026

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Could Be Riskier Than It Looks - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi6wFBVV95cUxPQkRpdXlyLTZBN1E2NlU5UnNOWHN3MnFWSVQzTUo5bTBkdWZSek9fdTk5SktxcEpwd3ZKRDU5N0RKN25YVjZBWkFvWkU4RGVWZ0x0SDZBQWJkSUpTMXZSS242YUJiTDJtSFE3eHRaMTFobTFabWtXRjhJS3JKNkE2ZjhCd2lDWjIydklucG…

Google News Sun, 26 Apr 2026

SNOA Drops As Sonoma Pharmaceuticals Launches Dilutive Offering - StocksToTrade

<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxOSlZiVWxMaW44cUtuQnlyekc2eVlOTnM3cUlrZmVUS01JYXRDc2tyNkpzcnI2eFFmOWRNTDd1TTN5aUhQdl9hbk16dy1haXZCVmNnbGxpc0tUUDZGc0I0ZHVTMWhMUEo1LV9CbkxTbDJKNWNiVGhDa3lBY3EyNHZ4QVNpQQ?oc=5" targe…

Google News Fri, 24 Apr 2026

Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxQaXlnNTR1RHVaR3ZnYUlvdGZhWFZaZkRqbXp2dmVyak5pcWNTaUJMeEVLWWJuOTc0UGowbUprWEFlaVRMd1J1WS1oR1hQNGIwYU4yY2hqaG9QWE5jRzhUeUw3VWtER1RiQjQ0aGtSb3Y5R3NhcWc2b2JhZm03Wm45TFl4VmFoYURadFFZdW…

Google News Fri, 31 Jul 2026

AST SpaceMobile Company Profile & Introduction - Moomoo

<a href="https://news.google.com/rss/articles/CBMiugJBVV95cUxQalpNSHAwbkZnNWdJWHdFTG9UUnV2eUdYenRDanVEUkhkanFvR0JKemJTWmJpLW5lOTJvejdTcm11SjhYWW1vSS1vb3YteFhRaEJWaHp1VExENFFTMHppQ2JGM2JhOFUyR0l4VkY3a0Y1SlRtMGFyMVhRMVBDdU1SSTROYUVRZksxMmpfYU…

SNOA — Frequently Asked Questions

What is the current share price of SNOA?

As of 2026-08-05 17:25 PDT, SNOA trades at $1.13 on NASDAQ/NYSE. Its 52-week range is $1.01 to $5.35.

What is the market capitalisation of SNOA?

SNOA has a market capitalisation of $2.03M on NASDAQ/NYSE.

What is the P/E ratio of SNOA?

SNOA trades at a trailing price-to-earnings (P/E) ratio of -0.60. Its price-to-book (P/B) ratio is 0.66.

What is the return on equity (ROE) of SNOA?

SNOA has a return on equity (ROE) of -102.58%. Its return on capital employed (ROCE) is -26.96%.

Is SNOA a good stock to buy?

This page provides a data-driven analysis of SNOA, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

SNOA SNOA

Company Overview

Why Investors Should Care

Recent Developments

Growth & Price Performance

Compounded Sales Growth

Stock Price Performance

Price Chart

Technical Trend

Fundamental Growth Charts

PROS

CONS

Valuation

Growth (CAGR)

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Quarterly Results

Profit & Loss (Annual)

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Shareholding Pattern

Analyst View

Latest News

Sonoma Pharma prices nearly 3M shares to fund working capital - Stock Titan

SNOA|Sonoma Pharmaceuticals Inc|Price:1.100|Chg%:-0.040 - TradingKey

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Could Be Riskier Than It Looks - simplywall.st

SNOA Drops As Sonoma Pharmaceuticals Launches Dilutive Offering - StocksToTrade

Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering - Yahoo Finance

AST SpaceMobile Company Profile & Introduction - Moomoo

SNOA — Frequently Asked Questions

What is the current share price of SNOA?

What is the market capitalisation of SNOA?

What is the P/E ratio of SNOA?

What is the return on equity (ROE) of SNOA?

Is SNOA a good stock to buy?

Explore More